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ABSTRACT
First described by Dr. Benjamin Castleman in 1956, Castleman disease is an 
uncommon disease of an etiology that is not yet thoroughly known. Three distinct 
histological subtypes have already been described: hyaline-vascular-, plasma 
cell-, and human herpes virus 8-associated variant, clinically distinguished 
in multi or unicentric types. Castleman disease is occasionally diagnosed 
in children, but more often in young adults, with no gender predominance. 
The symptoms are rather heterogeneous, varying from an asymptomatic 
mass in the unicentric Castleman disease type, to life-threatening systemic 
inflammatory state with systemic symptoms in the multicentric Castleman 
disease type. The authors report a case of a 15-year-old boy who sought 
medical attention due to a cervical tumor mass, without systemic symptoms. 
Pathology exam of the excised mass diagnosed a very typical example of the 
hyaline-vascular unicentric type of Castleman disease.
Keywords: Lymphoproliferative disorders; Giant lymph node hyperplasia; Biopsy; Lymph node 
excision.
CASE REPORT
A 15-year-old male patient sought medical 
attention complaining of a one-week history of pain 
on the right side of the neck and sore throat. The 
patient denied fever and other symptoms. Antibiotic 
and analgesic were prescribed. Thereafter the 
patient referred the appearance of painless tumor 
mass on the right side of the neck.
On physical static examination, a 4.5 cm 
nodule was evident on the right side of the neck. On 
palpation the tumor was painless, hard, not fixed to 
the surrounding tissues, and showed well-defined 
limits. The rest of the physical examination was 
unremarkable.
Ultrasonography revealed two enlarged 
right cervical lymph nodes measuring up to 3.0 cm 
and one increased lymph node on the left cervical 
chain measuring 1.0 cm. General laboratory workup 
was normal and serology for toxoplasmosis, 
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were consistent with the hyaline vascular type of 
Castleman disease (Figure 1).
An immunohistochemical study characterized 
better the diagnosis of Castleman disease and 
excluded lymphoma. The markers were: CD20 
(B lymphocytes), CD3 (T lymphocytes), CD138 
(plasma cells), CD21 (follicular dendritic cells), 
CD34 (vessels), HHV-8 (human herpes virus 8), KI-
67 (proliferative index, germinative centers), CD23 
(follicular dendritic cells), and IgD (mantle cells) 
(Figure 2).
DISCUSSION
Castleman disease, also called 
angiofollicular lymphoid hyperplasia or giant lymph 
node hyperplasia,1 was first described in 1956 by Dr. 
Benjamin Castleman, when he published a series of 
13 cases collected from the Massachusetts General 
Hospital, the Armed Forces Institute of Pathology, 
and the University of Havana. He defined it as a 
cytomegalovirus, hepatitis B virus, hepatitis C virus, 
hepatitis A virus, human immunodeficiency virus 
(HIV), and syphilis were all negative.
An excisional biopsy was performed and five 
irregular fragments consisting of lymphoid tissue 
were removed. The largest lymph node fragment 
measured 4.5 × 3.2 × 1.9 cm and was characterized 
by a brownish color at the cut surface and by a fibro-
elastic consistency.
Samples of excised tissues were incubated 
in a specific mycobacterial culture medium, which 
failed to show bacterial growth. The histopathological 
evaluation revealed lymphoid hyperplasia with 
an increased number of germinal centers and 
distinctive follicles with expanded mantle zones 
forming concentric rings surrounding one or more 
atrophic germinal centers. The germinal centers 
showed marked vascular proliferation, often with a 
single prominent penetrating hyalinised vessel. The 
interfollicular area also revealed marked vascular 
proliferation with hyaline change. These findings 
Figure 1 – Photomicrography of lymph node. A, B and C – Follicles with expanded mantle zones (onion 
skin) surrounding one or more atretic germinal centers with prominent vascularity; D – Vascular proliferation 
between the follicles, with perivascular hyalinization (HE – 400×).
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The disease is more prevalent in young 
adults without gender predominance, and is rare in 
children under the age of 18 years.
Since the first description, more than 500 
cases have been reported; out of them 57 were 
localized on the cervical region.5-7 In adults, lesions 
also have been found in the thorax (60%), abdomen 
(11%), and axilla (4%)8,9
In the pediatric population, until 1999, 83 
cases have been reported in the literature. Most 
of them were localized (86,7%), 27,7% in thoracic, 
20% in abdominal lymph nodes, 15,6% in cervical 
and 6% in axillary topography.10,11 More recently, 
Farruggia et al (2011) reviewing pediatric cases of 
Castleman disease, found a number of about 100 
reported cases.12 The cases of CD in childhood are 
mostly of unicentric hyaline-vascular type10, like in 
the case reported here.
The clinical features of Castleman disease 
are mostly related with its histological pattern. The 
distinct benign form of lymph node hyperplasia, 
characterized by germinal-center formation and 
marked capillary proliferation, which was later 
named as Hyaline-Vascular Castleman Disease.2 
In 1969, Flendrig and Schillings described another 
variant of this disease known as Plasma-Cell 
Castleman disease.3
Castleman disease is a lymphoproliferative 
disorder, characterized by polyclonal B lymphocyte 
proliferation,4 the etiology and pathogenesis of 
which is not yet thoroughly understood. Although 
the incidence is unknown, it is increasingly relevant 
today due to its association with HIV and HHV-8.1
Clinically the disease is defined as unicentric 
or multicentric and presents three main histological 
variants: hyaline-vascular-, plasma cell-, and HHV-
8-associated Castleman disease. The first two 
variants are of the unicentric type, whereas the 
third is of the multicentric type. Plasma-cell variant 
may also present in the multicentric type.1 A mixed 
variant with features of hyaline-vascular and plasma 
cell variants is also recognized.
Figure 2 – Photomicrography – (immunohistochemistry, 200×). A – CD21 positive (dendritic cells); B – Ki-
67 positive (germinal center); C – CD20 positive in lymphoid follicles; D – IgD positive in expanded mantle 
zone (200×).
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is mostly of plasma cell or plasmablastic variant. 
HIV-associated multicentric Castleman disease 
generally has a rapidly progressive clinical course 
showing, in large series, a median survival of 14 
months. The coinfection with HHV-8 may contribute 
to the poor outcome.1,15,16
The association of multicentric Castleman 
disease and non-Hodgkin lymphoma (NHL) is 
especially strong, but an association with Hodgkin 
lymphoma has also been reported. Besides the 
coexistence of Castleman disease and lymphoma, 
the progression of multicentric Castleman 
disease into lymphoma has also been reported.1 
In a prospective study involving 60 patients with 
multicentric Castleman disease and HIV, who were 
followed for 20 months, 23% developed NHL, at 
least half of which was aggressive plasmablastic 
lymphoma.1,15,17 A recent report shows an 
association with Epstein-Barr virus infection and 
Castleman disease, by extraction of DNA from 18 
cases of unicentric Castleman disease and 1 case 
of multicentric Castleman disease. This hypothesis 
has still to be validated since other reports failed to 
show this relationship.18,19
Castleman disease occurs frequently in 
association with autoimmune disease, and they likely 
share many features of pathophysiology. Among 
these autoimmune disorders are, systemic lupus 
erythematous, rheumatoid arthritis, scleroderma, 
polymyositis, mixed connective tissue disease, 
myasthenia gravis, paraneoplastic pemphigus, 
Evan’s syndrome, glomerulopathy, and POEMS 
(polyneuropathy, organomegaly [particularly 
hepatosplenomegaly], endocrinopathy, monoclonal 
gammopathy, and skin changes).4
Castleman disease is usually not the first 
suspicion for neck masses. The differential diagnosis 
includes infectious and inflammatory lesions 
such as nonspecific lymphadenitis, tuberculosis, 
sarcoidosis, toxoplasmosis, cytomegalovirus, as 
neurofibroma, cervical lipoma, thymoma, Hodgkin 
disease, NHL, and lymph node metastasis must 
be included3 in the differential diagnosis workup as 
well.
The diagnosis of Castleman disease is 
histopathological since most imaging diagnostic 
exams, such as computed tomography (CT) or 
magnetic resonance imaging (MRI) may help, but 
there is a lack of specific findings. Positron emission 
tomography-CT (PET-CT) scanning is effective in 
the diagnostic workup of unicentric or multicentric 
hyaline-vascular type is the most common variant of 
Castleman disease, accounting for 70% of patients 
and occurring predominantly in the fourth decade of 
life. The lesion is usually unicentric, involving a single 
node or a localized group of nodes. Mediastinal 
involvement is most common in this variant, but 
may also occur in the cervical, axillary, or abdominal 
regions.1 Clinically it is usually asymptomatic, being 
incidentally identified, except when associated 
symptoms induced by the mass effect are present. 
Histologically, it is characterized by follicles with 
expanded mantle zones of lymphocytes arranged in 
concentric “onion skin” layers. The germinal centers 
frequently demonstrate atrophy with penetrating 
blood vessels. There is a prominent proliferation 
of germinal centers vascularity and marked 
interfollicular vascular proliferation with perivascular 
hyalinization.
The plasma cell type may be clinically 
of unicentric or multicentric presentation. When 
unicentric (10-20% of cases), it affects an aggregate 
mass of lymph nodes and is accompanied by less 
systemic symptoms compared with the multicentric 
variant.
Although multicentric Castleman disease 
is less common (10%), it is far more varied in 
clinical manifestation. Systemic symptoms are the 
presenting feature in most cases and may be severe 
and life threatening. The most common clinical 
findings include disseminated lymphadenopathy, 
constitutional symptoms, such as fever, fatigue, night 
sweats, malaise, hepatomegaly, splenomegaly, and 
skin rash. The patient may become edematous; 
develop ascites, pleural and pericardial effusion.1,13 
In children, growth retardation may be one of the 
clinical symptoms.14 Laboratory findings include 
hypergammaglobulinaemia, chronic disease pattern 
anemia or hemolysis, thrombocytopenia, elevated 
erythrocyte sedimentation rate, hypoalbuminemia, 
and abnormal liver function tests.1 These clinical 
features seem to be related to the overproduction of 
IL-6 by the affected lymph nodes.3,14 In this variant, 
the mean age of presentation is the sixth decade. 
Histologically, it is less characteristic than the 
hyaline vascular type. The lymph node architecture 
is preserved; variable germinal center hyperplasia 
is observed, with expanded mantle zones, and a 
marked paracortical plasmocytosis.
The HHV-8 associated multicentric 
Castleman disease is still being elucidated. It may 
be related to HIV coinfection, independently of 
the CD4 count. In this case Castleman disease 
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Castleman disease as well as in the follow-up 
examinations.13 PET-CT is able to detect abnormal 
high uptake in non-enlarged nodes as well, thus 
helping in more accurate staging and monitoring of 
the disease.20
The treatment of choice for the unicentric 
hyaline-vascular variant is surgical excision, which 
is accompanied by good prognosis. In this case, 
surgical excision promoted the diagnosis as well as 
the therapeutics, providing a complete recovery.21,22 
On the other hand, due to its disseminated nature, 
complete resection is rarely possible for the 
multicentric type, therefore demanding systemic 
therapy. In this setting, high doses of steroids, 
chemotherapy alone, combined therapy and anti-
IL-6 monoclonal antibodies7 are used, despite the 
poor prognosis characteristic of this variant.
CONCLUSION
Due to the low incidence of Castleman 
disease and the physician’s unfamiliarity, 
misdiagnosis or delayed diagnosis is frequent. This 
observation becomes more relevant in pediatrics. 
Therefore the disease has to be included in the 
differential diagnosis of lymph node enlargement, 
anemia and B-symptoms. In the localized diseases, 
total tumoral exeresis should be performed for both 
therapeutic and diagnostic purposes.
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